I watched it and the mgmt confidence in the results including safety is really high. The primary focus will be on TGA and subsequently FDA engagement/ approval.
On commercial front Tom spoke highly of Neuren and GW pharma (drug epidiolex, which was acquired by Jazz pharma). This is the most exciting bit for me as a new SH.
I watched it and the mgmt confidence in the results including...
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.003(4.92%) |
Mkt cap ! $63.07M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.4¢ | 6.1¢ | $68.45K | 1.089M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 86601 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 12.20pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.4¢ |
Change
0.003 ( 4.92 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.4¢ | 6.2¢ | 303271 | ||
| Last updated 12.35pm 17/06/2024 ? | |||||
| NTI (ASX) Chart |
